Literature DB >> 19917694

Systematic classification of primary immunodeficiencies based on clinical, pathological, and laboratory parameters.

Crina Samarghitean1, Csaba Ortutay, Mauno Vihinen.   

Abstract

The classification of diseases has several important applications ranging from diagnosis and choice of treatment to demographics. To date, classifications have been successfully created manually, often within international consortia. Some groups of diseases, such as primary immunodeficiencies (PIDs), are especially hard to nosologically cluster due, on one hand, to the presence of a wide variety of disorders and, in contrast, because of overlapping characteristics. More than 200 PIDs affecting components of the innate and adaptive immune systems have been described. Clinical, pathological, and laboratory characteristics were collected and used to group PIDs. A consensus of at least five independent methods provided a novel classification of 11 groups, which revealed previously unknown features and relationships of PIDs. Comparison of the classification to independent features, including the severity and therapy of the diseases, functional classification of proteins, and network vulnerability, indicated a strong statistical support. The method can be applied to any group of diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19917694     DOI: 10.4049/jimmunol.0901837

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Waleed Al Herz; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Alain Fischer; Jose Luis Franco; Raif S Geha; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Chaim M Roifman; Reinhard Seger; Mimi L K Tang; Jennifer M Puck; Helen Chapel; Luigi D Notarangelo; Jean-Laurent Casanova
Journal:  J Clin Immunol       Date:  2013-05-09       Impact factor: 8.317

Review 2.  How should we approach classification of autoinflammatory diseases?

Authors:  Gilles Grateau; Véronique Hentgen; Katia Stankovic Stojanovic; Isabelle Jéru; Serge Amselem; Olivier Steichen
Journal:  Nat Rev Rheumatol       Date:  2013-07-09       Impact factor: 20.543

Review 3.  Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

4.  BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes.

Authors:  P V Soeiro-Pereira; A Falcai; C A Kubo; E B Oliveira-Júnior; O C Marques; E Antunes; A Condino-Neto
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

5.  Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York State.

Authors:  Elena S Resnick; Priyanka Bhatt; Peter Sidi; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2012-09-01       Impact factor: 8.317

6.  Simulation of the dynamics of primary immunodeficiencies in CD4+ T-cells.

Authors:  Gabriel N Teku; Mauno Vihinen
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Simulation of the Dynamics of Primary Immunodeficiencies in B Cells.

Authors:  Gabriel Ndipagbornchi Teku; Mauno Vihinen
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

Review 8.  Maternal Immunoglobulins in Infants-Are They More Than Just a Form of Passive Immunity?

Authors:  Kateryna Pierzynowska; Jarosław Woliński; Björn Weström; Stefan G Pierzynowski
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

Review 9.  Neurological Manifestations of Primary Immunodeficiencies.

Authors:  Zahra Chavoshzadeh; Amir Hashemitari; Sepideh Darougar
Journal:  Iran J Child Neurol       Date:  2018
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.